For the quarter ended March 2025, Sight Sciences, Inc. (SGHT) reported revenue of $17.51 million, down 9.1% over the same period last year. EPS came in at -$0.28, compared to -$0.33 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $16.53 million, representing a surprise of +5.95%. The company delivered an EPS surprise of +3.45%, with the consensus EPS estimate being -$0.29.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Sight Sciences performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Dry Eye: $0.39 million compared to the $0.23 million average estimate based on three analysts. The reported number represents a change of -60.9% year over year.
- Revenue- Surgical Glaucoma: $17.11 million versus $16.23 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -6.3% change.
- Gross Profit - Dry Eye: $0.28 million versus the two-analyst average estimate of $0.07 million.
- Gross Profit - Surgical Glaucoma: $14.82 million versus $14.09 million estimated by two analysts on average.
View all Key Company Metrics for Sight Sciences here>>>
Shares of Sight Sciences have returned +21.7% over the past month versus the Zacks S&P 500 composite's +11.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Sight Sciences, Inc. (SGHT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
